ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0013

Binding of CXCL13 with Heparan Sulfate of Syndecan-1 Plays an Important Role in Pathogenesis of Sjögren’s Syndrome

Eon Jeong Nam1, Na Ri Kim1 and Gun Woo Kim2, 1Kyungpook National University Chilgok Hospital, Daegu, Republic of Korea, 2Daegu Fatima Hospital, Daegu, Republic of Korea

Meeting: ACR Convergence 2022

Keywords: B-Lymphocyte, chemokines, Sjögren's syndrome

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 12, 2022

Title: B Cell Biology and Targets in Autoimmune and Inflammatory Disease Poster

Session Type: Poster Session A

Session Time: 1:00PM-3:00PM

Background/Purpose: Sjögren’s syndrome (SS) is a chronic autoimmune disorder with lymphocytic infiltration in exocrine and non-exocrine epithelia, in which epithelial cells play a critical role in the initiation and amplification of inflammatory processes. Syndecan-1 (SDC-1) is a transmembrane heparan sulfate proteoglycan predominantly expressed on epithelial cells and binds to and regulates heparan sulfate-binding molecules, such as chemokines. In this study, we investigated the expression of SDC-1 and homeostatic chemokines and the colocalization and association of SDC-1 and B cell chemokines in mouse model of primary SS to define the role of SDC-1 in the pathogenesis of SS.

Methods: Female NOD/ShiLtJ between 6 and 12 weeks of age and sex-, and age-matched C57BL10 mice were used. Stimulated salivary flow rates (SFRs), histopathologic findings and expression of growth factor and chemokines were evaluated. Inflammation of the submandibular glands (SMGs) was assessed by the ratio index (the ratio of the area of inflammation to the total area of glandular tissue). SDC-1 level in SMGs and blood were analyzed using dot blot method. Immunofluorescence staining was performed for detection of colocalization of CXCL13 and SDC-1. For SDC-1 and CXCL13 coassociation experiments, immunoprecipitation assay was performed.

Results: The mean SFR was significantly reduced in 12-week-old NOD mice (p=0.013). Periductal inflammatory cell infiltration was detected in the SMGs in 1 of 8 (12.5%) of the 6-week-old and in all of 12-week-old NOD mice. The mean ratio index was 0.1, 4.0, 7.1, and 10.2 in the 6-, 8-, 10-, and 12-week-old NOD mice, respectively. The expression of SDC-1 in inflamed SMGs of NOD mice was elevated, especially on the ductal epithelial cells, and tended to increase as the glandular inflammation progressed. Compared to controls, the concentration of SDC-1 in the SMGs and blood of NOD mice began to increase significantly from the age of 6 weeks (SMGs, 15.6±3.6 vs. 3.5±1.2, p=0.049; Blood, 17.4±1.3, 9.7±1.6, p=0.005). In the NOD mice, the concentration of SDC-1 of SMGs and blood began to be significantly different from the age of 10 weeks (6-week-old vs. 10-week-old mice, SMGs, 15.6±3.6 vs. 25.8±2.7, p=0.033; Blood, 17.4±1.3 vs. 27.7±1.2, p< 0.001).

Compared to controls, the expression of growth factors in NOD mice was reduced, while the expression of chemokines (CXCL12, CXCL13 and IL-7) and chemokine receptors (CXCR4, CXCR5) was increased. CXCL13 and SDC-1 were detected together on the surface of glandular epithelial cells in the SMGs by immunofluorescent staining. Furthermore, colocalization of SDC-1 and CXCL13 was confirmed by immunofluorescent staining using NMuMG cells which express SDC-1 abundantly. Immunoprecipitation studies demonstrated that SDC-1 formed complexes with CXCL13, which suggested that SDC-1 binds with CXCL13 directly through heparan sulfate on the surface of glandular epithelial cells and participates in an inflammatory pathway through B cell chemotaxis.

Conclusion: These results suggested that increased SDC-1 expression in submandibular glands plays a role in the inflammatory processes through binding of SDC-1 with CXCL13 in pathogenesis of SS.


Disclosures: E. Nam, None; N. Kim, None; G. Kim, None.

To cite this abstract in AMA style:

Nam E, Kim N, Kim G. Binding of CXCL13 with Heparan Sulfate of Syndecan-1 Plays an Important Role in Pathogenesis of Sjögren’s Syndrome [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/binding-of-cxcl13-with-heparan-sulfate-of-syndecan-1-plays-an-important-role-in-pathogenesis-of-sjogrens-syndrome/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/binding-of-cxcl13-with-heparan-sulfate-of-syndecan-1-plays-an-important-role-in-pathogenesis-of-sjogrens-syndrome/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology